Dyne Therapeutics plans USD 300 million common stock offering, with USD 45 million option for underwriters
DYN•Planned common stock offering
Dyne Therapeutics plans to raise USD 300 million in an underwritten public offering of common stock.
It also plans to give underwriters a 30-day option to buy up to an additional USD 45 million of shares.
The offering is subject to market conditions.
